Welcome to our animal welfare page.
Here, you will find exciting insights into the subject of animal welfare and the ever-evolving state of research. Discover the latest fascinating topics and new scientific advances, and expand your knowledge of the ‘3R’ principle (Reduce, Refine, Replace). The 3R principle is the catalyst that drives our efforts and plays a crucial role in minimizing animal testing, optimizing its implementation and promoting alternative methods that enable animal testing to be replaced – always with the aim of improving animal welfare in the long term.
However, the fact is that animal experiments are still indispensable for researching pervasive diseases such as various forms of cancer, multiple sclerosis or Alzheimer’s and for developing new treatment approaches. Many patients rely on effective therapies that significantly improve their quality of life. That is why it is all the more important that pharmaceutical companies give top priority to handling laboratory animals responsibly and that the 10-point Animal Welfare Charter signed by Interpharma’s member companies, launched in 2010, is applied consistently.
This page also contains the comprehensive Animal Welfare Report, which looks at current developments and progress in this field.
Best regards,
Dr. René P. Buholzer
CEO, Interpharma
The COVID-19 pandemic reminded us of the devastating consequences that the transmission of pathogens from animals to humans can have. It’s not only the animals themselves that suffer from epidemics and diseases. According to the One Health approach, they need a good supply of medicines to protect their own health and that of humans.
The COVID-19 pandemic reminded us of the devastating consequences that the transmission of pathogens from animals to humans can have. It’s not only the animals themselves that suffer from epidemics and diseases. According to the One Health approach, they need a good supply of medicines to protect their own health and that of humans.
The systematic use of the 3Rs principles of Reduce, Refine and Replace have led to significant improvements in preclinical research over the last few decades. The reduction in animal experiments could be even greater if alternative methods were more widely recognised by the regulatory authorities. But what else might be possible if data from in vivo experiments was centrally available and widely shared?
Subthemen
The Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International is an independent non-profit organisation that promotes animal welfare in science through voluntary evaluation and accreditation programmes. Several research sites belonging to Interpharma member companies are AAALAC certified.
Breakthrough innovative medicines and treatments are partly the result of animal experiments. Given the biological similarities between humans and animals, it is possible to transfer the results of experiments.
Subthemen
Animals that are used for experiments in Switzerland are generally bred specifically for this purpose. How the animals are bred, kept, transported and received at the destination laboratory is strictly regulated. Animal well-being comes first at all times.
Subthemen
Research institutions keep more animals than they use in experiments. Daniel Breustedt, Team Leader in the Scientific Operations/Comparative Medicine department at Novartis’ NIBR, explains why this cannot be completely avoided and what options are available for reducing animal use.
Subthemen
Just a year after the outbreak of the pandemic, various highly effective vaccines were already available. The first highly automated coronavirus tests also allowed test capacity to be ramped up early on. Without the responsible use of animals this would not have been possible.
Subthemen
Today, the pharmaceutical industry thinks holistically about well-being in medical research: animal welfare and a caring corporate culture go hand in hand.
In 2016, the Netherlands considered a complete ban on animal experiments by 2025. The plan was rejected: it is not possible without animal experiments.
With its cross-border collaboration, the research-based pharmaceutical industry is making an unparalleled effort to combat the Covid-19 crisis. And animal experiments form a part of this effort that is indispens- able for the development of new medicines and vaccines
Subthemen
Ten years ago, research-based pharmaceutical companies in Switzerland committed to the responsible handling of animals in research with the 10-point Animal Welfare Charter, which set the ball rolling not only in Switzerland but also internationally.
Subthemen
Animal welfare legislation in Switzerland is one of the strictest worldwide. Animal experiments may only be conducted if no alternatives are available.
Many years of high-precision work and interdisciplinary expertise go into a medicine. To ensure that medication is reliably effective in humans, research with animals is absolutely essential in the development of new medicines.
Animal welfare legislation in Switzerland is among the strictest in the world. Animal experiments may only be carried out if no alternatives are available. Strict regulations also apply for the housing of laboratory animals, as they do for the training and continuing education of researchers who work with animals.
Die Entwicklung von Organoiden markiert einen Wendepunkt in der biomedizinischen Forschung. Organoide bilden menschliche Organe nach. Sie ermöglichen realitätsnahe Krankheitsmodelle und tragen dazu bei, Tierversuche gemäss dem 3R-Prinzip zu reduzieren oder ganz zu ersetzen.
Subthemen
